JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online May 15, 2008, 10.2967/jnumed.107.047548
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnumed.107.047548v1
49/6/907    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kasama, S.
Right arrow Articles by Kurabayashi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kasama, S.
Right arrow Articles by Kurabayashi, M.
Journal of Nuclear Medicine Vol. 49 No. 6 907-914
© 2008 by Society of Nuclear Medicine

doi: 10.2967/jnumed.107.047548

Clinical Investigation

Prognostic Value of Serial Cardiac 123I-MIBG Imaging in Patients with Stabilized Chronic Heart Failure and Reduced Left Ventricular Ejection Fraction

Shu Kasama1,2, Takuji Toyama1, Hiroyuki Sumino2, Minato Nakazawa3, Naoya Matsumoto4, Yuichi Sato4, Hisao Kumakura2, Yoshiaki Takayama2, Shuichi Ichikawa2, Tadashi Suzuki1 and Masahiko Kurabayashi1

1 Department of Medicine and Biological Science (Cardiovascular Medicine), Gunma University Graduate School of Medicine, Gunma, Japan; 2 Department of Internal Medicine, Cardiovascular Hospital of Central Japan, Gunma, Japan; 3 Department of Public Health, Gunma University Graduate School of Medicine, Gunma, Japan; and 4 Department of Cardiology, Nihon University School of Medicine, Tokyo, Japan

Correspondence: For correspondence or reprints contact: Shu Kasama, Department of Medicine and Biological Science (Cardiovascular Medicine), Gunma University Graduate School of Medicine, 3-39-15, Showa-machi, Maebashi, Gunma 371-0034, Japan. E-mail: s-kasama{at}bay.wind.ne.jp

Many studies have shown that a one-time 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphic study during a stable period is useful for determining the prognosis of patients with chronic heart failure (CHF). However, the findings from this imaging modality are well known to be improved by medical treatment for heart failure. Accordingly, this study was performed to determine whether serial 123I-MIBG scintigraphic studies represent a reliable prognostic marker for patients with CHF. Methods: A total of 208 patients with CHF (left ventricular ejection fraction [LVEF] < 45%) and with no cardiac events for at least 5 mo were identified on the basis of a history of decompensated acute heart failure requiring hospitalization. The delayed percentage of denervation (% denervation), delayed heart-to-mediastinum count (H/M) ratio, and washout rate (WR) were determined from the patients' 123I-MIBG images just before they left the hospital and after they had received 6 mo of treatment. The left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and LVEF were also determined by echocardiography at the same time points. Results: Of the 208 patients, 56 experienced fatal cardiac events during the study. The mean follow-up period was 4.45 ± 1.82 y. The baseline H/M ratio and WR; follow-up % denervation, H/M ratio, and WR; {Delta}-% denervation, H/M ratio, and WR; baseline LVEF; follow-up LVEDV, LVESV, and LVEF; and {Delta}-LVEDV, {Delta}-LVESV, and {Delta}-LVEF were significantly worse in the cardiac death group. A Cox regression analysis showed that the {Delta}-WR was an independent predictor of cardiac death. Moreover, sudden death occurred in 13 of the 56 patients with cardiac death. A Cox regression analysis also showed that the {Delta}-WR was an incremental predictor of sudden death. The cardiac death–free rate and sudden death–free rate were significantly higher in patients with {Delta}-WR less than –5% and {Delta}-WR less than –2% than in patients with {Delta}-WR greater than or equal to –5% and {Delta}-WR greater than or equal to –2%. Conclusion: {Delta}-WR obtained from serial 123I-MIBG scintigraphic studies can be useful for predicting cardiac death and sudden death in stabilized patients with CHF.

Key Words: heart failure • prognosis • sympathetic nervous system • scintigraphy

COPYRIGHT © 2008 by the Society of Nuclear Medicine, Inc.


Related articles in JNM:

This Month in JNM

JNM 2008 49: 13A-14A. [Full Text]  



This article has been cited by other articles:


Home page
J Am Coll Cardiol ImgHome page
S. G. Drakos, T. Athanasoulis, K. G. Malliaras, J. V. Terrovitis, N. Diakos, D. Koudoumas, A. S. Ntalianis, S. P. Theodoropoulos, M. H. Yacoub, and J. N. Nanas
Myocardial Sympathetic Innervation and Long-Term Left Ventricular Mechanical Unloading
J. Am. Coll. Cardiol. Img., January 1, 2010; 3(1): 64 - 70.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll Cardiol ImgHome page
I. Carrio, M. R. Cowie, J. Yamazaki, J. Udelson, and P. G. Camici
Cardiac Sympathetic Imaging With mIBG in Heart Failure
J. Am. Coll. Cardiol. Img., January 1, 2010; 3(1): 92 - 100.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.